Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World February 15, 2007 Victoria Gill	Novartis Contests India's Patent Law Swiss pharmaceutical company Novartis has accused the Indian government of failing to comply with WTO rules after it refused to grant the company a patent on its cancer drug Glivec.
Chemistry World April 8, 2013 Sarah Houlton	India rejects Novartis patent appeal India's Supreme Court has denied Novartis' appeal against the decision to refuse patent protection for its anticancer drug Glivec (imatinib mesylate).
Chemistry World March 20, 2012 Rajesh Parishwad	India Green Lights Production of Patented Cancer Drug For the first time India has invoked a 'compulsory license' clause to cut the cost of a patented anti-cancer drug by allowing another company to manufacture the therapy.
BusinessWeek April 18, 2005 Manjeet Kripalani	India: Bigger Pharma Tougher patent protection laws are spurring rapid growth in new drug research across India.
Chemistry World August 24, 2009 Sarah Houlton	Indian court dismisses Bayer's patent law case Bayer has failed in its attempt to stop Indian regulators giving marketing authorization to a generic version of its kidney cancer drug Nexavar (sorafenib), despite its 20 year patent having only been granted last year.
Chemistry World September 17, 2010 Andrew Turley	Free trade could throttle generics from India International agreements on intellectual property threaten the flow of generic HIV drugs from India to developing countries, according to a new report.
Pharmaceutical Executive October 1, 2011 Amrita Ghaswalla	Changing the Dialogue No industry leader is more closely associated with the goal of seeding the globe with low-cost generics than Mumbai-based Cipla Chairman Y.K. Hamied.
The Motley Fool March 31, 2010 Brian Orelli	When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.
The Motley Fool March 28, 2005 Brian Gorman	A Passage to India? Changes in India's patent law could create new dynamics for the biotech and pharmaceutical industries. Investors should be on the lookout for the firms that seek to leverage these new opportunities.
InternetNews June 9, 2011	Microsoft Loses Supreme Court Patent Case Top U.S. court rules against Microsoft in i4i patent appeal.
Chemistry World January 7, 2015 Rebecca Trager	Myriad loses appeal on cancer gene test patents Myriad Genetics has lost its appeal over patents on the BRCA genes that are associated with a higher risk of breast and ovarian cancer.
InternetNews November 30, 2010	Microsoft's i4i Appeal Headed for Supreme Court Microsoft will get a chance to make its case to the U.S. Supreme Court, appealing the earlier patent infringement decision it lost to i4i.
Chemistry World March 9, 2011 Andrew Turley	Court halts EU patent progress The intellectual property community will have to wait a little longer for its one-size-fits-all European patent, following a key ruling from the Court of Justice of the European Union
Chemistry World April 2012 Darren Smyth	Be Careful What You Wish for The struggle for a single unitary European patent may be close to an end, but we must still hold out for an agreement that performs as it should.
Chemistry World January 21, 2013 Andy Extance	India pushes for emergency drug licenses The Indian government is preparing to grant compulsory licenses allowing three patented cancer drugs to be produced in the country and sold at reduced rates without permission from the patent owners.
Chemistry World August 14, 2015 Jennifer Newton	No one should be denied medication 'My whole fight today, for the third world, is for access to medicine at affordable prices,' attests Indian generics manufacturer Cipla chairman Yusuf Hamied.
Chemistry World August 2, 2013 Phillip Broadwith	India revokes more pharma patents India's Intellectual Property Appellate Board has revoked one of two patents granted to GlaxoSmithKline for its cancer drug lapatinib.
The Motley Fool August 31, 2011 John Grgurich	How the Patent Wars Are Hurting High-Tech Well-intentioned patent laws are threatening to stifle innovation.
IEEE Spectrum February 2006 Lee A. Hollaar	Patents 2.0 There are big problems with patents, especially software patents. A new type of patent is needed -- Congress should create a new, limited protection that protects against knockoffs without overreaching.
Pharmaceutical Executive April 1, 2014 Subramanian et al.	"Market-Based" Price Controls In India? Three strategic implications for pharma pricing strategies in India.
Chemistry World July 25, 2012	Pharma Industry May Suffer as India Looks to Generics India plans to provide free generic drugs to half its population.
Knowledge@Wharton	Drug Companies and the Patent Game: Fair Play or Foul? Is legal maneuvering a legitimate attempt by the big pharmaceutical companies to recover the huge costs of developing new drugs? Or are the brand-name firms inappropriately gaming the system for their own benefit, to the detriment of consumers and insurance companies?
CIO September 28, 2011 Grant Gross	Controversial Business-Method Patents Face New Attacks A new law revamps the patent system and gives rivals an eight-year window to challenge IT-related patents in the financial-services industry.
Chemistry World July 11, 2012 Ling Wang	China Targets Patented Drugs with Law Change China has altered its licensing laws to allow domestic pharmaceutical companies to make cheap generic copies of patented drugs under certain circumstances.
Inc. July 24, 2002 Jennifer A. Redmond	Strategic Patenting What to consider when you're filing a patent and strategic decisions you'll need to make.
InternetNews February 16, 2007 Roy Mark	Patent Reform: Beware of Unintended Consequences Is it fair to patent software?
InternetNews September 3, 2009	Microsoft: Can't Our Patent Systems Get Along? Senior Microsoft legal eagle advocates "harmonization" of patent systems worldwide in blog post.
Wall Street & Technology September 19, 2006 Paul Allen	Patent Processing For both the patent holders and potential transgressors, technology patents can be a high-stakes game in the financial world, in both monetary awards and ongoing business feasibility.
Information Today September 15, 2011 George H. Pike	Congress Enacts Patent Reform Legislation In what is being described as the most substantial overhaul of U.S. patent law in nearly 60 years, Congress passed the Leahy-Smith America Invents Act, patent reform legislation that has been years in the making.
InternetNews June 11, 2004 Susan Kuchinskas	Microsoft Patent in Review The United States Patent and Trademark Office granted a request by the Public Patent Foundation to review one of Microsoft's many patents, the organization said today.
Information Today October 16, 2006 K. Matthew Dames	The Patent System on Tilt: IBM Seeks to Change the Game IBM wants to change the way the patent system works, holding itself out as an exemplar of openness.
Chemistry World July 11, 2012	Europe-Wide Single Patent Stalls Again A single European patent is on the wish list of small innovative businesses.
Chemistry World January 26, 2009 Jia & Yuan	China pushes for higher quality patents In an effort to boost the quality of patent applications, and encourage Chinese firms to obtain international patents, China has revised its patent law.
Chemistry World May 21, 2009 Matt Wilkinson	Big Pharma set for generics boost Pharmaceutical firms have been rushing to ensure they minimize their losses by expanding their generics businesses and reach into emerging markets.
Chemistry World March 23, 2012 Rebecca Trager	Court throws out patent covering drug dosing The US Supreme Court has said that medical tests that rely on correlations between drug doses and treatment cannot be patented because they are based on laws of nature.
InternetNews January 10, 2006 Clint Boulton	USPTO Joins Patent Quality Cause The United States Patent and Trademark Office teams with IBM and the OSDL to improve the way patents are constructed and issued in the U.S.
Pharmaceutical Executive April 1, 2012 William Looney	IP: Time for a Reset? Patents are the chief incentive for drug development. Industry should educate stakeholders about IP protection as a crucial driver of innovation, before it's too late.
Entrepreneur October 2005 Chris Penttila	Patent Pending Have an idea for the next big thing? You'll need a patent, but pay attention to big changes in store for U.S. patent law.
IndustryWeek October 1, 2007 Jill Jusko	Patent Protection Your valuable intellectual property requires keen oversight. To help keep it safe, consider these actions.
Pharmaceutical Executive October 1, 2010	Euro Soul-Searching on Competition A report by the European Commission aimed at exploring patent exploitation by Big Pharma winds up generating more angst than answers.
CIO September 28, 2012 Kim S. Nash	Companies Race to the Patent Office to Protect Their IT Breakthroughs There's a patent gold rush under way as savvy companies seek to lock in the competitive advantage from their IT innovations. CIOs ought to seek patents for unique business methods and other inventions made possible by new technology.
The Motley Fool October 3, 2007 Rich Duprey	No Patents on Thinking ... Yet Over the years, the U.S. Patent office has patented a few too many ideas. The Supreme Court is now spending more time deciding whether a company has really infringed on a patent, rather than automatically issuing an infringement.
IEEE Spectrum June 2007 Suhas Sreedhar	Peer Review Starts for Software Patent Applications Hoping to curtail the orgy of tech-industry litigation, the U.S. Patent and Trademark Office recently launched an Internet-based peer-review program whereby anyone can help to evaluate a number of software patent applications voluntarily submitted for public evaluation.
Chemistry World July 10, 2013 Darren Smyth	How to invent and protect your invention Even as an account of US patent law, this book, by Kennedy et al., has little to commend it. It is difficult to understand in many places, the selection of topics for coverage is peculiar, and is downright wrong in many details.
The Motley Fool March 13, 2008 Stephen Albainy-Jenei	Pfizer's Celebrex Aches and Pains The Court of Appeals for the Federal Circuit upholds a lower court's ruling that found Teva Pharmaceutical had infringed two of Pfizer's patents for Celebrex.
Salon.com March 19, 2001 Ben Barber	Fighting the plague The World Trade Organization steps into Africa's AIDS crisis, creating incentives for pharmaceutical companies to give some of their drugs away.
Entrepreneur September 2006 Jane Easter Bahls	Toppling Trolls Patent trolls take a hit in a Supreme Court ruling.
InternetNews March 30, 2005 Tim Gray	EBay Wins Patent Ruling If the action is upheld it would invalidate the MercExchange patent that led to a $25 million judgment against eBay over the "Buy It Now" feature.
The Motley Fool January 8, 2010 Brian Orelli	Heartburn Relieved ... for Now AstraZeneca settles its patent dispute with Teva.
Salon.com March 21, 2001 Damien Cave	Patents are your friends Can open-source programmers use intellectual property laws to protect themselves from corporate software snatchers? Publishing work on IP.com ensures the patent office will see it and not issue patent for the idea to someone else.